Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 2608 of 5804
-
A 3D-printed model may transform ostomy education — a trial puts it to the test
Symptom relief Recruiting nowThe purpose of this study is to evaluate the feasibility of using a realistic and anatomically accurate 3D printed simulation model for urologic bowel diversion patient education. Using a randomized two group design, we aim to determine whether the use of this model enhances pati…
Phase: NA • Sponsor: University of Minnesota • Aim: Symptom relief
Last updated Jul 24, 2026 00:00 UTC
-
New epilepsy drug safety check: 660 patients monitored long-term
Disease control ENROLLING_BY_INVITATIONA study to determine if BHV- 7000 is safe and tolerable in adults with refractory focal onset epilepsy
Phase: PHASE2 • Sponsor: Biohaven Therapeutics Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
Can free healthy meals and group support lower heart risks in black communities?
Disease control CompletedThis study is a human-centered, three-arm, parallel-group, randomized control, implementation trial (n=75) to compare MTM (Medically Tailored Meals) only (14 meals delivered weekly for 10 weeks) vs. MTM + SMA (Shared Medical Appointments; once weekly sessions for 10 weeks) vs. a …
Phase: NA • Sponsor: Amanda Shallcross • Aim: Disease control
Last updated Jun 27, 2026 08:02 UTC
-
Dual relief: tailored exercise eases heart and knee woes
Symptom relief CompletedExercise-based cardiac rehabilitation (CR) has been shown to significantly improve cardiovascular health and overall well-being in patients with congestive heart failure (CHF). However, a substantial number of CHF patients also suffer from comorbid conditions, such as knee osteoa…
Phase: NA • Sponsor: Riphah International University • Aim: Symptom relief
Last updated Jun 27, 2026 09:08 UTC
-
New study aims to slow memory decline with caregiver support
Symptom relief Recruiting nowWith the aging of the population, an increase in neurocognitive diseases such as dementia is projected. Mild cognitive impairment is considered a precursor stage to dementia, with opportunities for intervention to prevent its progression. Additionally, these illnesses can harm th…
Phase: NA • Sponsor: Universidad de Santander • Aim: Symptom relief
Last updated Jun 27, 2026 12:31 UTC
-
Can eye drops save sight during ovarian cancer treatment?
Symptom relief Recruiting nowThe purpose of this study is to evaluate the incidence rate and severity of prespecified mirvetuximab soravtansine (MIRV)-related ocular treatment-emergent adverse events (TEAEs) and assess prophylaxis strategies in all participants (symptomatic and asymptomatic) undergoing prosp…
Phase: PHASE2 • Sponsor: AbbVie • Aim: Symptom relief
Last updated Jun 27, 2026 13:06 UTC
-
Text message workouts could ease strain on hearts of PAH patients
Symptom relief OngoingThe purpose of this study is to evaluate whether a home rehabilitation program for patients diagnosed with Pulmonary Arterial Hypertension (PAH) will decrease Cardiac Effort (number of heart beats used during 6-minute walk test/walk distance) and improve quality of life. Ultimate…
Phase: NA • Sponsor: University of Rochester • Aim: Symptom relief
Last updated Jul 17, 2026 00:00 UTC
-
Can MS patients safely switch to a gentler drug?
Disease control Recruiting nowA multi-center pilot study to evaluate safety and efficacy of ozanimod as de-escalation therapy in clinically stable MS patients previously treated with anti-CD20 therapy.
Phase: PHASE4 • Sponsor: University of Colorado, Denver • Aim: Disease control
Last updated Jun 26, 2026 17:32 UTC
-
Promising drug shows hope for rare skin condition
Disease control CompletedThe purpose of this study is to evaluate the safety and effectiveness of Deucravacitinib (BMS-986165) in Pityriasis Rubra Pilaris as assessed by the change in Investigator Global Assessment (IGA), PASI- 50, 75, 90, DLQI, NRS itch, and Skindex-16 at week 24. To predict responses t…
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Can a home therapy program stop repeat falls in dementia patients?
Symptom relief Recruiting nowThis project will enable optimization of specific carried out by occupationist for older adults discharged from hospital for falls: * on the environmental dimension at the participant's home * on the involvement of the caregiver since they are also involved in the care of the pa…
Phase: NA • Sponsor: University Hospital, Limoges • Aim: Symptom relief
Last updated Jun 27, 2026 08:11 UTC
-
Can we predict chronic pain after trauma? new study seeks answers
Knowledge-focused Recruiting nowThis study aims to assess multidimensional risk factors for chronic post-traumatic pain in polytrauma patients. The purpose is to better understand pain chronification mechanisms by quantifying the interaction between clinical, biological, therapeutic, and psychosocial factors du…
Sponsor: University Hospital, Montpellier • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:00 UTC
-
AI could spot diabetic eye disease in minutes
Diagnosis OngoingThis research study is being conducted to improve eye care by using artificial intelligence (AI) to make diabetic eye screenings faster and more accessible. AI technology mimics human decision-making, enabling computers and systems to analyze medication information. Specifically …
Phase: NA • Sponsor: Centro De Salud La Comunidad De San Ysidro Inc DBA: San Ysidro Health • Aim: Diagnosis
Last updated Jun 27, 2026 07:56 UTC
-
New headset therapy may reduce need for repeat eye surgeries in kids
Disease control CompletedIntermittent exotropia is difficult to treat. The mainstay of treatment involves surgery, and in one long-term study authors found that as many as 60% of IXT required at least one re-operation.Patching of the non-dominant eye has also been tested in a large, multi-center randomiz…
Phase: NA • Sponsor: Virginia Commonwealth University • Aim: Disease control
Last updated Jul 17, 2026 00:00 UTC
-
New cancer drug combo enters first human tests
Disease control Recruiting nowThe main goal of this first-in-human (FIH) study is to learn about the safety and dosing of GS-2121 when given alone or in combination with zimberelimab (ZIM) in participants with advanced solid tumors. The primary objectives of this study are: * To assess the safety and tolera…
Phase: PHASE1 • Sponsor: Gilead Sciences • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Can an AI chatbot cure your sleepless nights?
Symptom relief OngoingInsomnia is a common sleep problem, which affects 9.4-38.2% of youths worldwide. Youth insomnia is linked to mental health problems, leading to substantial health and economic burden. The project aims to conduct an assessor-blind, randomized controlled trial to evaluate the effic…
Phase: NA • Sponsor: Chinese University of Hong Kong • Aim: Symptom relief
Last updated Jun 27, 2026 11:03 UTC
-
New pill aims to keep narcolepsy patients awake during the day
Symptom relief CompletedThe purpose of this study is to measure the safety and decrease in sleepiness in subjects with narcolepsy type 2 (NT2) when taking ALKS 2680 tablets compared to placebo tablets.
Phase: PHASE2 • Sponsor: Alkermes, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 09:09 UTC
-
Could a sleep drug curb stimulant cravings?
Symptom relief Recruiting nowThe purpose of this study is to determine the effects of suvorexant (SUVO), on sleep, stress, and drug craving during early abstinence from stimulants and to determine the effects of treatment (SUVO vs. treatment as usual (TAU)) on post-treatment (Days 13-30) residential program …
Phase: PHASE2 • Sponsor: The University of Texas Health Science Center, Houston • Aim: Symptom relief
Last updated Jun 26, 2026 14:13 UTC
-
Blood clot boost for knee surgery: new trial aims to prevent arthritis
Disease control Recruiting nowLongitudinal meniscal tears are a type of meniscal injury characterized by a displaced fragment of the meniscus that flips over into the joint, often resembling a buckle or handle. These tears typically occur in the medial meniscus and are often associated with traumatic knee inj…
Phase: NA • Sponsor: Ankara City Hospital Bilkent • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
Could a simple buzz replace needles' fear? stanford tests vibrating device on 1,100 patients
Symptom relief OngoingThis pragmatic, randomized study seeks to evaluate the applications of a novel vibrating device for reducing pediatric anxiety and distress during vascular access procedures.
Phase: NA • Sponsor: Stanford University • Aim: Symptom relief
Last updated Jun 27, 2026 08:08 UTC
-
App aims to ease chronic pain in underserved communities
Symptom relief Recruiting nowThe purpose of this study is to examine the feasibility of the dissemination of a cognitive-behavioral eHealth application (app) for pain self-management with Black and LGBTQ+ adults with high-impact chronic pain lasting at least 3 months and disrupting daily functioning (Impleme…
Phase: NA • Sponsor: Mayo Clinic • Aim: Symptom relief
Last updated Jun 27, 2026 09:04 UTC